Endogenous acetylcholine controls the severity of polymicrobial sepsisassociated inflammatory response in mice

Current Neurovascular Research

Volumn 13, Issue 1, 2016, Pages 4-9

  Amaral, Flavio Almeida ^a   Fagundes, Caio Tavares ^a   Miranda, Aline Silva ^a   Costa, Vivian Vasconceios ^a   Resende, Livia ^a   Da Gloria De Souza, Danielle ^a   Prado, Vania Ferreira ^b,c   Teixeira, Mauro Martins ^a   Prado, Marco Antonio Maximo ^b,c   Teixeira, Antonio Lucio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Acetylcholine; Inflammation; Neutrophils; Nicotine; Sepsis

Indexed keywords

ACETYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA; NICOTINE; NICOTINIC AGENT; SLC18A3 PROTEIN, MOUSE; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR; VESICULAR ACETYLCHOLINE TRANSPORTER;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; FEMALE; INFLAMMATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEPSIS; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; CELL MOTION; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LIGATION; METABOLISM; MICROBIOLOGY; MORTALITY; NEUTROPHIL; PERITONEAL CAVITY; PHYSIOLOGY; TRANSGENIC MOUSE; TYPHLITIS;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; CELL MOVEMENT; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, BACTERIAL; LIGATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUTROPHILS; NICOTINE; NICOTINIC AGONISTS; PERITONEAL CAVITY; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA; TYPHLITIS; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 84959261314     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/1567202612666151026105915     Document Type: Article

References (35)

1. Fernandez R, Nardocci G, Navarro C, Reyes EP, Acuna-Castillo C, Cortes PP. Neural reflex regulation of systemic inflammation: potential new targets for sepsis therapy. Front Physiol 2014; 5: 489.
2. Terrando N, Yang T, Ryu JK, Newton PT, Monaco C, Feldmann M, Daqing Ma, Akassoglou K, Mervyn Maze. Stimulation of the α7 nicotinic acetylcholine receptor protects against neuroinflammation after tibia fracture and endotoxemia in mice. Mol Med 2015; 20: 667-75.
3. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009; 9:418-428.
4. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2001; 405: 458-462.
5. Bencherif M, Lippiello PM, Lucas R, Marrero MB: Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci 2011; 68: 931-949.
6. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
7. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG: The pathogenesis of sepsis. Annu Rev Pathol 2011; 6: 19-48.
8. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470- 474.
9. Secher T, Vasseur V, Poisson DM, et al. Crucial role of TNF receptors 1 and 2 in the control of polymicrobial sepsis. J Immunol 2009; 182: 7855-7864.
10. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330: 662-664.
11. Pfeffer K, Matsuyama T, Kundig TM, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993; 73: 457-467.
12. Fisher CJ, Jr Agosti JM, Opal SM, et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996; 334: 1697-1702.
13. Clark MA, Plank LD, Connolly AB, et al. Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis-a randomized, clinical trial. Crit Care Med 1998; 26: 1650-1659.
14. Remick D, Manohar P, Bolgos G, et al. Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 1995; 2: 89-95.
15. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-251.
16. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006; 6: 173-182.
17. Appelberg R: Neutrophils and intracellular pathogens: beyond phagocytosis and killing. Trends Microbiol 2007; 15: 87-92.
18. Alves-Filho JC, Spiller F, Cunha FQ. Neutrophil paralysis in sepsis. Shock 2010; 34 Suppl 1: 15-21.
19. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-388.
20. Pavlov VA, Ochani M, Yang LH, et al. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med 2007; 35: 1139- 1144.
21. Prado VF, Martins-Silva C, de Castro BM, et al. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 2006; 51: 601-612.
22. Martin EL, Souza DG, Fagundes CT, et al. Phosphoinositide-3 kinase gamma activity contributes to sepsis and organ damage by altering neutrophil recruitment. Am J Respir Crit Care Med 2010; 182: 762-773.
23. Tayarani IC, Changeux JP. Nicotine and serotonin in immune regulation and inflammatory processes: A perspective. J Leukoc Biol 2007; 81(3): 599-606.
24. Godshall CJ, Scott MJ, Peyton JC, et al. Genetic background determines susceptibility during murine septic peritonitis. J Surg Res 2002; 102: 45-49.
25. Grau GE, Maennel DN. TNF inhibition and sepsis sounding a cautionary note. Nat Med 1997; 3: 1193-1195.
26. Thomson CA, McColl A, Cavanagh J, Graham GJ. Peripheral inflammation is associated with remote global gene expression changes in the brain. J Neuroinflammation. 2014; 8:73.
27. Kim TH, Kim SJ, Lee SM. Stimulation of the α7 nicotinic acetylcholine receptor protects against sepsis by inhibiting Toll-like receptor via phosphoinositide 3-kinase activation. J Infect Dis 2014; 209: 1668-1677.
28. Benjamim CF, Ferreira SH, Cunha FQ: Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis 2000; 182: 214-223.
29. Torres-Duenas D, Celes MR, Freitas A, et al. Peroxynitrite mediates the failure of neutrophil migration in severe polymicrobial sepsis in mice. Br J Pharmacol 2007; 152: 341-352.
30. Hoffmeyer F, Witte K, Schmidt RE. The high-affinity Fc gamma RI on PMN: Regulation of expression and signal transduction. Immunology 1997; 92: 544-552.
31. Zarbock A, Allegretti M, Ley K. Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice. Br J Pharmacol 2008; 155: 357-364.
32. Freitas A, Alves-Filho JC, Trevelin SC, S et al. Divergent role of heme oxygenase inhibition in the pathogenesis of sepsis. Shock 2011; 35: 550-559.
33. Chishti AD, Shenton BK, Kirby JA, Baudouin SV. Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med 2004; 30: 605-611.
34. Alves-Filho JC, de Freitas A, Russo M, Cunha FQ. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit Care Med 2006; 34: 461-470.
35. Alves-Filho JC, Freitas A, Souto FO, et al. Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci 2009; 106: 4018-4023.